4.6 Article

Is the objective of the Water Framework Directive to deal with pollutant emissions at source coherently implemented by the EU's substance-specific legal acts? A comparison of the environmental risk control of pharmaceutical legislation with the REACH-, Biocidal Products- and Plant Protection Products Regulation

期刊

SUSTAINABLE CHEMISTRY AND PHARMACY
卷 20, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.scp.2021.100386

关键词

Water Framework Directive; Pharmaceuticals; Environmental Risk Assessement; Environmental Quality Standards

资金

  1. law office Teppe Hamburg
  2. Hamburg University of Applied Sciences (HAW Hamburg), Ulmenliet, Hamburg

向作者/读者索取更多资源

The study shows that the objectives of the Water Framework Directive are not consistently implemented by the substance-specific legal acts of the Union. While regulatory frameworks for industrial chemicals, biocides, and pesticides have implemented various instruments to achieve environmental objectives, pharmaceutical legislation is lacking in comparison. This highlights the need to incorporate similar instruments in pharmaceutical legislation to ensure coherence with the Water Framework Directive.
The general objectives of the Water Framework Directive (WFD) are achieving good surface water and groundwater status, the reduction of pollution by priority substances and the prevention or limit inputs of pollutants into groundwater, whereby pollutant emissions are to be dealt with at source. The present study shows that these objectives are not coherently implemented by the substance-specific legal acts of the Union. While the three regulatory frameworks for industrial chemicals, biocides and pesticides have implemented instruments such as: - the centralisation and statutory establishment of the environmental risk assessment, - the post-market control of environmental risks, - a programme for old substances not (sufficiently) assessed for environmental risks, - the substitution of environmentally hazardous substances, - the public participation and transparency with regard to the integration of environmental concerns, that help to achieve the environmental objectives and also strengthen the interaction between substance law and environmental protection law through explicit links, the pharmaceutical legislation shows considerable deficits in comparison. Even though the active pharmaceutical ingredient diclofenac will be added to the list of priority substances in the near future, the current instruments of the pharmaceutical legislation will not be able to react at source when a defined environmental quality standard is exceeded. As a result, the legal framework of pharmaceuticals in its current form cannot meet the environmental objectives of the WFD. To create the legal requested coherence between the substance-specific legal acts and the WFD, the instruments listed above can and should be enshrined in the pharmaceutical legislation as well.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据